Sigma Planning’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
Other funds holding STRO
Sigma Planning's STRO Position: Q3 2026 in Review
Sigma Planning sold out of Sutro Biopharma (STRO) in Q3 2026, closing a stake of 45,020 shares — an estimated $1.49M sold.
Sigma Planning first reported a position in STRO in Q1 2026 and held it in 2 quarters. The position peaked at $1.49M in Q2 2026. 60 funds tracked by Wall St. Rank hold STRO as of Q3 2026.
- Sigma Planning reported no remaining Sutro Biopharma position as of Q3 2026 after selling out during the quarter.
- Sigma Planning sold 45,020 Sutro Biopharma shares in Q3 2026, an estimated $1.49M.
- Sigma Planning first reported a position in Sutro Biopharma in Q1 2026 and held it in 2 quarters.
- Sigma Planning's Sutro Biopharma position peaked at $1.49M in Q2 2026.
- 60 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.
Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.